New strategies for the treatment of acute myelogenous leukemia: differentiation induction—present use and future possibilities

Ø Bruserud, BT Gjertsen - Stem cells, 2000 - academic.oup.com
A differentiation block and an accumulation of immature myeloid cells characterize acute
myelogenous leukemia (AML). However, native AML cells usually show some …

Induction of differentiation and apoptosis—a possible strategy in the treatment of adult acute myelogenous leukemia

Ø Bruserud, BT Gjertsen, T Huang - The Oncologist, 2000 - academic.oup.com
A differentiation block with accumulation of immature myeloid cells characterizes acute
myelogenous leukemia (AML). However, native AML cells often show some morphological …

Sipa1 deficiency–induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm

P Xiao, M Dolinska, L Sandhow, M Kondo… - Blood …, 2018 - ashpublications.org
Mutations of signal-induced proliferation-associated gene 1 (SIPA1), a RAP1 GTPase-
activating protein, were reported in patients with juvenile myelomonocytic leukemia, a …

Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs

L Oevermann, J Scheitz, K Starke… - … journal of cancer, 2009 - Wiley Online Library
Several types of peripheral blood cells express ABC transporters. ABCC4 (MRP4) and
ABCC5 (MRP5) localize to different cellular sites and fulfill lineage‐specific functions such …

Reduced proliferation of non-megakaryocytic acute myelogenous leukemia and other leukemia and lymphoma cell lines in response to eltrombopag

CL Erickson-Miller, J Kirchner, M Aivado, R May… - Leukemia Research, 2010 - Elsevier
Leukemia cell lines were treated with eltrombopag or thrombopoietin and their proliferative
response was determined. Eltrombopag did not increase proliferation of cell lines that did …

Use of EBV-based vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms

H Hirai, E Satoh, M Osawa, T Inaba… - Biochemical and …, 1997 - Elsevier
Targeted suicide gene therapy for Epstein-Barr virus (EBV)-associated neoplasms was
attempted by using EBV-based plasmid vectors coupled with hemagglutinating virus of …

Endogenous TPO (eTPO) levels in health and disease: possible clues for therapeutic intervention

JL Nichol - Stem Cells, 1998 - Wiley Online Library
The factor which is the primary regulator of megakaryocyte and platelet production has
recently been identified as the ligand for the receptor Mpl. This discovery has resulted in …

Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer

Y Harada, M Iwai, S Tanaka, T Okanoue… - Cancer gene …, 2000 - nature.com
The present study was aimed at devising an efficient nonviral strategy for suicide gene
therapy of hepatocellular carcinoma (HCC). To improve the efficiency of DNA delivery and …

Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia

F Corazza, C Hermans, S D'Hondt, A Ferster, A Kentos… - Blood, 2006 - ashpublications.org
Thrombopoietin (TPO), the major growth factor for cells of the megakaryocytic lineage, is
removed from circulation by binding to c-mpl receptors present on platelets and …

Effects of sodium stibogluconate on differentiation and proliferation of human myeloid leukemia cell lines in vitro

MK Pathak, X Hu, T Yi - Leukemia, 2002 - nature.com
PTPases are key signaling molecules and targets for developing novel therapeutics. We
have studied the in vitro biological activity of PTPase inhibitor sodium stibogluconate (SS) …